Sacheerome Ltd
Sacheerome Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.
Based on Sacheerome Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
For H2 FY26, total income was ₹7,806.30 Lakhs, up 35.57% from ₹5,758.16 Lakhs in H2 FY25 (Page 20). Quarter (H2 FY26) EBITDA: ₹1,955.98 Lakhs, up 48.77% YoY from ₹1,314.79 Lakhs in H2 FY25 (Page 20) - Quarter (H2 FY26) PAT: ₹1,350.43 Lakhs, up 51.19% YoY from ₹893.23 Lakhs in H2 FY25 (Page 2
From Sacheerome Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- For H2 FY26, total income was ₹7,806.30 Lakhs, up 35.57% from ₹5,758.16 Lakhs in H2 FY25 (Page 20).
- H2 FY26 revenue was ₹7,582.08 Lakhs versus ₹5,708.09 Lakhs in H2 FY25, showing robust year-on-year growth (Page 20).
- Domestic sales for FY26 were ₹14,294.98 Lakhs compared to ₹9,933.08 Lakhs in FY25; export sales were ₹943.60 Lakhs vs ₹820.51 Lakhs in FY25 (Page 18).
2 more points management made on revenue & sales performance
Profitability & Margins
See what Sacheerome Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Establishing a modern infrastructure facility in YEIDA, Uttar Pradesh, including R&D, Quality, Application, and Consumer Evaluation Centers (Page 26).
- Land for the new manufacturing facility acquired in YEIDA; construction is underway, and machinery has been identified and ordered (Page 26).
- The expansion aims to enhance production capacity, market reach, and technological advancements (Page 27).
- No specific capex amounts or detailed timelines are provided in the presentation.
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Sacheerome Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Continue your research
What Sacheerome Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
- Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
- Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…
- Chemfab Alkalis Ltd (Q1 FY27)
Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key concall takeaways from Chemfab Alkalis Ltd's Q1…
Frequently Asked Questions
What were Sacheerome Ltd Q1 FY27 results?
For H2 FY26, total income was ₹7,806.30 Lakhs, up 35.57% from ₹5,758.16 Lakhs in H2 FY25 (Page 20). Quarter (H2 FY26) EBITDA: ₹1,955.98 Lakhs, up 48.77% YoY from ₹1,314.79 Lakhs in H2 FY25 (Page 20) - Quarter (H2 FY26) PAT: ₹1,350.43 Lakhs, up 51.19% YoY from ₹893.23 Lakhs in H2 FY25 (Page 2
What is Sacheerome Ltd share price analysis?
Sacheerome Ltd currently shows a neutral. The stock trades at a P/E of 42.4 with a market cap of ₹1,201 Cr. Investors should review the full earnings analysis for detailed insights.
Is Sacheerome Ltd planning capital expenditure?
Establishing a modern infrastructure facility in YEIDA, Uttar Pradesh, including R&D, Quality, Application, and Consumer Evaluation Centers (Page 26).
Keep Sacheerome Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.